Author(s):
A.K. Sadanov, I.A. Ratnikova, S.E. Orasymbet, Ye.Zh. Shorabayev, B.B. Baymakhanova, L.Ye. Protasyuk, A.D. Massirbayeva
Email(s):
amankeldi.sadanov@yandex.ru , bbbayken@mail. ru
DOI:
10.52711/0974-360X.2024.00904 
Address:
A.K. Sadanov1*, I.A. Ratnikova2, S.E. Orasymbet2, Ye.Zh. Shorabayev2, B.B. Baymakhanova1*, L.Ye. Protasyuk1, A.D. Massirbayeva2
1Research and Production Center for Microbiology and Virology LLP, Almaty, Kazakhstan.
2Industrial Microbiology LLP, Almaty, Kazakhstan.
*Corresponding Author
Published In:
Volume - 17,
Issue - 12,
Year - 2024
ABSTRACT:
In recent years, preparations based on lactic acid bacteria have proven to be effective in the complex therapy of infectious diseases. Despite the large number of positive results of the use of these preparations and their widespread use, there are some risks associated with their use. To minimize these risks, it is necessary to regulate the production, sale, and use of probiotic preparations on an equal basis with medicines. To date, there are no made-in-Kazakhstan probiotic preparations with clinically proven safety and performance in the pharmaceutical market of Kazakhstan. The purpose of this paper was to present preclinical trials of this preparation confirming its safety and medical performance and demonstrate the readiness for clinical trials of the Kazakh probiotic medication AS-Probionorm. The AS-Probionorm probiotic medication developed by us based on an association of specific action lactic acid bacteria (Lactobacillus fermentum 30 and Lactobacillus cellobiosus 36), has high antimicrobial activity against pathogens of intestinal diseases. This study introduces AS-Probionorm as the first locally produced probiotic in Kazakhstan with clinically established safety and effectiveness, marking a significant step forward in the national production of biomedical health solutions.
Cite this article:
A.K. Sadanov, I.A. Ratnikova, S.E. Orasymbet, Ye.Zh. Shorabayev, B.B. Baymakhanova, L.Ye. Protasyuk, A.D. Massirbayeva. Developing Safe Probiotic Solutions for the Treatment of Human Intestinal Infections. Research Journal Pharmacy and Technology. 2024;17(12):5960-6. doi: 10.52711/0974-360X.2024.00904
Cite(Electronic):
A.K. Sadanov, I.A. Ratnikova, S.E. Orasymbet, Ye.Zh. Shorabayev, B.B. Baymakhanova, L.Ye. Protasyuk, A.D. Massirbayeva. Developing Safe Probiotic Solutions for the Treatment of Human Intestinal Infections. Research Journal Pharmacy and Technology. 2024;17(12):5960-6. doi: 10.52711/0974-360X.2024.00904 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-12-41
REFERENCES:
1. Stavropoulou, E., and Bezirtzoglou, E. Probiotics in medicine: a long debate. Frontiers in Immunology. 2020; 11; 2192.
2. Yang, Y., et al. Bile salt hydrolase can improve Lactobacillus plantarum survival in gastrointestinal tract by enhancing their adhesion ability. FEMS Microbiology Letters. 2019; 366(8): fnz100.
3. Plaza-Diaz, J., et al. Mechanisms of action of probiotics. Advances in Nutrition. 2019; 10(suppl_1): 49-66.
4. Gavrilova, N. N., et al. Study on immunomodulatory properties of probiotic microorganisms and their associations. Микробиология Жəне Вирусология. 2018; 19.
5. Sangeetha Sundaramoorthy, Selvakumar Selvaraj, Vidhya Kameshwari. Antibacterial Activity of Lactobacillus Species Isolated from Dairy products against Antibiotics. Research J. Pharm. and Tech. 2020; 13(8): 3915-3917.
6. Anbarasu Sivaraj, Vanaja Kumar, Revathy Kalyanasundaram, Govindaraju Kasivelu. Biogenic production of Gold nanoparticles using Lactic acid bacteria and their Anti-mycobacterial activity. Research J. Pharm. and Tech. 2020; 13(9): 4391-4394.
7. De Oliveira, G. L. V., et al. Intestinal dysbiosis and probiotic applications in autoimmune diseases. Immunology. 2017; 152(1): 1-12.
8. Ranjan, A. The Use of Probiotics, Prebiotics, and Synbiotics as an Alternative to Antibiotics. In Alternatives to Antibiotics: Recent Trends and Future Prospects. Singapore: Springer Nature Singapore. 2022; 449-465.
9. Md Kamal Hossain, Kamrun Nahar, Parisa Shokryazdan, Norhani Abdullah, Kaiser Hamid, Mohammed Faseleh Jahromi. Probiotic Potential of Lactic Acid Bacteria Isolated from Cheese, Yogurt and Poultry Faeces. Research J. Pharm. and Tech. 2017; 10(9): 2991-2998.
10. Do Carmo, M. S., et al. Probiotics, mechanisms of action, and clinical perspectives for diarrhea management in children. Food and Function. 2018; 9(10): 5074-5095.
11. Gavrilova, N. N., et al. The effectiveness of dry probiotic in the treatment and prevention of salmonellosis. International Journal of Pharmaceutical Research. 2018; 10(4): 626-631.
12. Gavrilova, N. N., et al. Developing of Lactic-Acid and Propionic Bacteria Association that is Efficient against the Causes of Colibacteriosis and Salmonellosis. Biotechnology in Russia. 2005; 2: 24-33.
13. Lukasik, J., et al. Probiotics for the prevention of antibiotic-associated adverse events in children—A scoping review to inform development of a core outcome set. PLOS One. 2020; 15(5): e0228824.
14. Ma, Y., et al. Which probiotic has the best effect on preventing Clostridium difficile‐associated diarrhea? A systematic review and network meta‐analysis. Journal of Digestive Diseases. 2020; 21(2): 69-80.
15. McFarland, L. V., and Goh, S. Are probiotics and prebiotics effective in the prevention of travellers’ diarrhea: a systematic review and meta-analysis. Travel Medicine and Infectious Disease. 2019; 27: 11-19.
16. Shi, X., et al. Efficacy and safety of probiotics in eradicating Helicobacter pylori: A network meta-analysis. Medicine. 2019; 98(15).
17. Alfaleh, K., and Anabrees, J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evidence-Based Child Health. 2014; 9(3): 584–671.
18. Underwood, M.A. Probiotics and the prevention of necrotizing enterocolitis. J Pediatr Surg. 2019; 54(3): 405–412.
19. Hudson, L.E., et al. Gleaning insights from fecal microbiota transplantation and probiotic studies for the rational design of combination microbial therapies. Clin Microbiol Rev. 2017; 30(1): 191–231.
20. Samer M. Al-Hulu. Antibacterial activity for Bacteriocin produced by Lactic acid bacteria against Clinical Bacterial Isolates. Research J. Pharm. and Tech. 2019; 12(9): 4205-4208.
21. Shalini Singh, Sujata Das. Evaluation of Market Curd for Sanitary Quality and Bacteriocin-Producing Lactic acid Bacteria for Potential Application as a Natural, Healthy Food Preservative. Research J. Pharm. and Tech. 2017; 10(4): 1029-1033.
22. Pankaj Prashar, Pardeep Kumar, Ankita Sood, Anamika Gautam, Harmeet Kaur, Arvinder Kaur, Ruksaar Ebrahim, Shubham Sharma, Indu Melkani, Narendra Kumar Pandey, Bimlesh Kumar. Investigation of selected 13 FDA approved drugs for TRPV1 Antagonism using molecular docking: An insight application for the treatment of Neuronal pain. Research J. Pharm. and Tech. 2020; 13(11): 5328-5332.
23. Lerner, A., Matthias, T., and Aminov, R. Potential effects of horizontal gene exchange in the human gut. Frontiers in Immunology. 2017; 8: 1630.
24. Zheng, M., et al. Assessing the risk of probiotic dietary supplements in the context of antibiotic resistance. Frontiers in Microbiology. 2017; 8: 908.
25. Lerner, A., Shoenfeld, Y., and Matthias, T. Probiotics: if it does not help it does not do any harm. Really? Microorganisms. 2019; 7(4): 104.
26. M. Indira, T.C. Venkateswarulu, K. Chakravarthy, A. Ranganadha Reddy, K. Vidya Prabhakar. Isolation and Characterization of Bacteriocin Producing Lactic Acid Bacteria from Diary Effluent. Research J. Pharm. and Tech. 2015; 8(11): Nov. 1560-1565.
27. Rao, S. S. C., et al. Brain fogginess, gas, and bloating: a link between SIBO, probiotics and metabolic acidosis. Clinical and Translational Gastroenterology. 2018; 9(6).
28. Kozhanov, Z., Serikbayeva, A., Kozhanova, N., Sydykov, D., Sadvakassov, K., and Mukhametkaliev, M. Impact of Functional Foods on Improving the Health of the Kazakh Population. Advancements in Life Sciences. 2023; 10(4).
29. Shevchenko, T.V., Ustinova, Yu.V., Ermolaeva, E.O., Popov, A.M., and Uzunov, G.B. Extending the Storage Life of Foods Using Shungite. Advancements in Life Sciences. 2023; 10(2): 152-156.
30. Spesivtseva, A., Gvarzhdets, N., Autlev, K., Kruchinin, E., and Kuznetsov, I. Diseases of the Neuroacanthocytosis Group: A Systematic Review of Clinical Cases and Difficulties in their Diagnosis. Advancements in Life Sciences. 2023; 10(3).
31. Sadanov, A.K., Gavrilova, N.N., Ratnikova, I.A., Orazymbet, S.E., Protasiuk, L.E., and Massirbaeva, A.D. Technology for the production of Lyophilizate of an association of Lactic acid bacteria included in the Medicinal product AS-Probionorm. Research Journal of Pharmacy and Technology. 2023; 16(11): 5334-0. doi: 10.52711/0974-360X.2023.00864
32. Bakırhan, H., and İncedal Irgat, S. Dietary Patterns and Cardiovascular Risk: Are the Mediterranean Diet, the Heart-Healthy Diet, and Phytochemicals Associated with Lower Cardiovascular Risks? Iran J Public Health. 2023; 52(12): 2611-2620.
33. Gavrilova, N.N., Ratnikova, I.A., Sadanov, A.K., Orazymbet, S.E., Shorabaev, E.Zh., and Protasiuk, L.E. Development of Technology for the production of finished forms of Medicinal probiotics. Research Journal of Pharmacy and Technology. 2023; 16(9): 4093-4. doi: 10.52711/0974-360X.2023.00670
34. Luo, D., Wang, J., Wang, Z., Fang, F., Kang, Y., and Chen, O. The Development Trend of Medical Animals in the Last Ten Years: A Review. Iran J Public Health. 2023; 52(7): 1334-1345.
35. Alnadari, F., Abdin, M., Ennab, W., Mohedein, A., and Nasiru, M.M. Department of Food Science and Technology, Faculty of Agriculture and Agricultural Technology, Federal University, Dutsin-Ma, Katsina State, Nigeria. J Food Chem Nanotechnol. 2020; 6(4): 207-217.
36. Tran Thi Minh Thu, Doan Thi Thanh Vinh, Nguyen Anh Dung, Nguyen Hoang Khue Tu. Effect of Lactic Acid produced by Lactic acid bacteria on Prodigiosin production from Streptomyces coelicolor. Research Journal of Pharmacy and Technology. 2021; 14(4): 1953-6.
37. Young-Hoon Lee, Su-Chul Han, Hong-Ryang Jung, Cheong-Hwan Lim. A Preliminary Study for Dose Calculation using optically Stimulated Luminescence Dosimeters in High-Energy Radiation. Research J. Pharm. and Tech. 2017; 10(8): 2723-2728.